Indivior (NASDAQ:INDV) Stock Price Up 3%

Indivior PLC (NASDAQ:INDV) shares rose 3% on Monday . The stock traded as high as $19.89 and last traded at $19.89. Approximately 134,288 shares were traded during trading, an increase of 12% from the average daily volume of 120,170 shares. The stock had previously closed at $19.32.

Wall Street Analysts Forecast Growth

Separately, Craig Hallum began coverage on shares of Indivior in a research report on Wednesday, April 3rd. They set a “buy” rating and a $37.00 target price for the company.

Indivior Stock Performance

The firm has a 50 day moving average price of $20.38 and a two-hundred day moving average price of $18.41.

Indivior (NASDAQ:INDV) last issued its earnings results on Thursday, February 22nd. The company reported $0.43 earnings per share for the quarter, topping analysts’ consensus estimates of $0.28 by $0.15. The firm had revenue of $293.00 million during the quarter, compared to analyst estimates of $260.00 million. Indivior had a net margin of 0.18% and a return on equity of 538.18%. On average, research analysts forecast that Indivior PLC will post 2.03 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Indivior

Several institutional investors have recently modified their holdings of the company. Vanguard Group Inc. boosted its stake in Indivior by 0.9% in the fourth quarter. Vanguard Group Inc. now owns 5,899,190 shares of the company’s stock worth $90,081,000 after buying an additional 52,836 shares in the last quarter. Royal London Asset Management Ltd. raised its position in Indivior by 5.8% in the 4th quarter. Royal London Asset Management Ltd. now owns 447,828 shares of the company’s stock worth $6,838,000 after purchasing an additional 24,383 shares during the period. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main raised its position in Indivior by 53.6% in the 4th quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 176,976 shares of the company’s stock worth $2,673,000 after purchasing an additional 61,772 shares during the period. Madison Avenue Partners LP lifted its stake in Indivior by 84.9% in the fourth quarter. Madison Avenue Partners LP now owns 72,255 shares of the company’s stock worth $1,103,000 after purchasing an additional 33,168 shares during the last quarter. Finally, Legal & General Group Plc boosted its holdings in Indivior by 158.1% during the 4th quarter. Legal & General Group Plc now owns 12,927 shares of the company’s stock valued at $195,000 after acquiring an additional 7,919 shares during the period. 60.33% of the stock is currently owned by institutional investors.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.